close
Choose your channels

Baba Ramdev's Covid-19 'cure' raises too many doubts

Wednesday, June 24, 2020 • Telugu Comments
Listen to article
--:-- / --:--
1x
This is a beta feature and we would love to hear your feedback?
Send us your feedback to audioarticles@vaarta.com

As reported already, Baba Ramdev's Patanjali has come up with Coronil, a "cure" for Covid-19. Hours after it was launched on Tuesday, the AYUSH Ministry of the central government asked Patanjali to stop advertising it. It also directed the Ayurvedic company to submit details of the composition of Coronil and other important information.

Meanwhile, questions arise as regards the efficiency of the drug. Remember, Ramdev has claimed it to be a cure and not as a mere treatment.

Amid a raging controversy over Ramdev's claims, The Print on Wednesday reported that the clinical trials didn't involve symptomatic patients with co-morbidities. It's people with diabetes, hypertension and the like who are most vulnerable to coronavirus. Fatality rate among them is higher. Considering these factors, the clinical trials should have ideally involved such patients.

The portal says in its report that Patanjali chose mostly young people in the age group of 35-45 for the trials. That too, most of them showed only mild symptoms.

In all likelihood, Patanjali might be asked to stop advertising Coronil as a cure. It can be sold as an immunity-boosting treatment regime, perhaps.

Ashwagandha, Giloy and Tulsi are said to be the ingredients of the drug.

Follow us on Google News and stay updated with the latest!   

Comments

Welcome to IndiaGlitz comments! Please keep conversations courteous and relevant to the topic. To ensure productive and respectful discussions, you may see comments from our Community Managers, marked with an "IndiaGlitz Staff" label. For more details, refer to our community guidelines.
settings
Login to post comment
Cancel
Comment